Search
Cisplatin Treatment Options in Canada
A collection of 326 research studies where Cisplatin is the interventional treatment. These studies are located in the Canada . Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-small Cell Lung Cancer.
61 - 72 of 326
Show Filters
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Filter by Age
Filter by Type
Gender
Male
Female
Both
Type of Study
Interventional
Observational
Clinical Trial Phase
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
Unknown
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Recruiting
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and activity of divarasib combined with other anti-cancer therapies in participants with previously untreated, advanced or metastatic non-small cell lung cancer (NSCLC).
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and activity of divarasib combined with other anti-cancer therapies in participants with previously untreated, advanced or metastatic non-small cell lung cancer (NSCLC). Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/19/2025
Locations: City of Hope National Medical Center, Duarte, California +64 locations
City of Hope National Medical Center, Duarte, California
City of Hope - Seacliff, Huntington Beach, California
City of Hope at Irvine Lennar, Irvine, California
UCSD Moores Cancer Center, La Jolla, California
Yale Cancer Center, New Haven, Connecticut
NYU Langone Hospital - Long Island, Mineola, New York
NYU Cancer Center, New York, New York
Mount SInai Medical Center, New York, New York
MD Anderson Cancer Center, Houston, Texas
Oncology & Hematology Associates of Southwest Virginia, Inc, Blacksburg, Virginia
Virginia Oncology Associates, Norfolk, Virginia
Hospital Britanico, Buenos Aires, Not set
Clinica Adventista Belgrano, Ciudad Autonoma Buenos Aires, Not set
Centro Oncologico Riojano Integral (CORI), La Rioja, Not set
Concord Repatriation General Hospital, Concord, New South Wales
Peter MacCallum Cancer Centre, Melbourne, Victoria
Alfred Health, Melbourne, Victoria
Cliniques Universitaires St-Luc, Bruxelles, Not set
Jessa Zkh (Campus Virga Jesse), Hasselt, Not set
Clinique Ste-Elisabeth, Namur, Not set
AZ Delta (Campus Rumbeke), Roeselare, Not set
Hospital de Cancer de Barretos, Barretos, São Paulo
Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo
Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario
Princess Margaret Cancer Center, Toronto, Ontario
Jewish General Hospital, Montreal, Quebec
Hunan Cancer Hospital, Changsha CITY, Not set
Harbin Medical University Cancer Hospital, Harbin, Not set
Shanghai Pulmonary Hospital, Shanghai, Not set
Rambam Medical Center, Haifa, Not set
Rabin MC, Petach Tikva, Not set
Tel Aviv Sourasky Medical Ctr, Tel Aviv, Not set
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli, Campania
Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio
Irccs Istituto Nazionale Dei Tumori (Int), Milano, Lombardia
A.O. Universitaria S. Luigi Gonzaga, Orbassano, Piemonte
National Cancer Center Hospital East, Chiba, Not set
National Cancer Center Hospital, Tokyo, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Wakayama Medical University Hospital, Wakayama, Not set
Pusan National University Hospital, Busan, Not set
Seoul National University Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Korea University Guro Hospital, Seoul, Not set
NKI The Netherlands Cancer Institute, Amsterdam, Not set
UMC St Radboud, Nijmegen, Not set
Uniwersyteckie Centrum Kliniczne, Gda?sk, Not set
Krakowski Szpital Specjalistyczny im sw. Jana Paw?a II, Kraków, Not set
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie, Olsztyn, Not set
ICO Badalona-H.U. Germans Trias i Pujol, Badalona, Barcelona
Vall d?Hebron Institute of Oncology (VHIO), Barcelona, Barcelona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Hospital Clinico Universitario de Valencia, Valencia, Not set
Sahlgrenska University Hospital, Göteborg, Not set
Universitätsspital Basel, Basel, Not set
Inselspital Bern, Bern, Not set
Taichung Veterans General Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
National Taiwan Uni Hospital, Taipei, Not set
Chang Gung Medical Foundation - Linkou, Taoyuan, Not set
Beatson West of Scotland Cancer Centre, Glasgow, Not set
Barts & London School of Med, London, Not set
Conditions: Non-Small Cell Lung Cancer
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Recruiting
This is a global, multicenter, randomized, open-label study, with an adaptive design. The main objective of the study is to measure the efficacy and safety of BT8009 (zelenectide pevedotin) as monotherapy and in combination with pembrolizumab in participants with locally advanced or metastatic urothelial cancer (UC). The study includes a dose selection phase followed by an adaptive design continuation. The study is comprised of 2 cohorts. Cohort 1 will include participants who have not received... Read More
This is a global, multicenter, randomized, open-label study, with an adaptive design. The main objective of the study is to measure the efficacy and safety of BT8009 (zelenectide pevedotin) as monotherapy and in combination with pembrolizumab in participants with locally advanced or metastatic urothelial cancer (UC). The study includes a dose selection phase followed by an adaptive design continuation. The study is comprised of 2 cohorts. Cohort 1 will include participants who have not received any prior systemic therapy for locally advanced or metastatic UC and are eligible to receive platinum-based chemotherapy, whereas Cohort 2 will include participants who have received ≥ 1 prior systemic therapy for locally advanced or metastatic UC. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/19/2025
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas +169 locations
University of Arkansas for Medical Sciences, Little Rock, Arkansas
Virginia K. Crosson Cancer Center at St. Jude Medical Center, Fullerton, California
University of California - Irvine Medical Center, Orange, California
Adventist Health St. Helena, Saint Helena, California
University of California, San Francisco (UCSF), San Francisco, California
Rocky Mountain Cancer Center, Denver, Colorado
Yale University School of Medicine - Yale Cancer Center, New Haven, Connecticut
Medical Oncology Hematology Consultants, Newark, Delaware
Cancer Specialists of North Florida, Jacksonville, Florida
Mount Sinai Medical Center of Florida, Inc., Miami Beach, Florida
University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida
AP Medical Research, Miami, Florida
Moffitt, Tampa, Florida
Southern Illinois University (SIU) - Simmons Cancer Institute, Springfield, Illinois
Mission Cancer + Blood, Des Moines, Iowa
University of Kansas Cancer Center, Westwood, Kansas
UofL Health Brown Cancer Center, Louisville, Kentucky
Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana
Princess Margaret Hospital, Grand Rapids, Michigan
Nebraska Cancer Specialists, Omaha, Nebraska
XCancer Omaha/Urology Cancer Center, Omaha, Nebraska
Astera Cancer Care, East Brunswick, New Jersey
Summit Health (New Jersey Urology), Voorhees, New Jersey
Montefiore Medical Center, Bronx, New York
Columbia University Irving Medical Center, New York, New York
University Hospitals Cleveland Medical Center, Cleveland, Ohio
Medical University of South Carolina (MUSC) - Hollings Cancer Center, Charleston, South Carolina
Carolina Urologic Research Center, Myrtle Beach, South Carolina
SCRI Oncology Partners, Nashville, Tennessee
The Center for Cancer and Blood Disorders, Fort Worth, Texas
MD Anderson Cancer Center, Houston, Texas
University of Texas Health Science Center at San Antonio, San Antonio, Texas
Centro de Diagnostico Urologico S.R.L., Buenos Aires, Not set
Hospital Britanico de Buenos Aires, Buenos Aires, Not set
Hospital Sirio Libanes de Buenos Aires, Buenos Aires, Not set
Instituto Alexander Fleming, Buenos Aires, Not set
Fundacion Medica Rio Negro y Neuquen, Cipolletti, Not set
Centro Medico Privado (CEMAIC), Córdoba, Not set
Fundación CORI para la investigación y Prevención del Cancer, La Rioja, Not set
Centro De Investigacion Pergamino S.A., Pergamino, Not set
Instituto de Oncologia de Rosario, Santa Fe, Not set
Clinica Viedma S.A., Viedma, Not set
Cancer Research SA, Adelaide, Not set
Mater Misericordiae Ltd, South Brisbane, Brisbane, Not set
Townsville Hospital and Health Service, Douglas, Not set
Barwon Health, Geelong, Not set
Calvary Mater Newcastle, Hunter, Not set
Sir Charles Gairdner Hospital, Nedlands, Not set
Blacktown Hospital, New South Wales, Not set
Prince of Wales Hospital, Randwick, Not set
Icon Cancer Centre, South Brisbane, Not set
Gold Coast University Hospital, Southport, Not set
Princess Alexandra Hospital, Woolloongabba, Not set
Urologie und Andrologie Ordensklinikum Linz GmbH Elisabethinen, Linz, Not set
Krankenhaus der Barmherzigen Brüder Wien, Wien, Not set
Medizinische Universitaet Wien, Wien, Not set
ASBL Grand Hôpital de Charleroi (GHdC), Site Notre Dame, Charleroi, Not set
General Hospital Maria Middelares, Gent, Not set
University Hospital Gent, Gent, Not set
Universitaire Ziekenhuizen Leuven, Leuven, Not set
Fundacao PIO XII - Hospital de Amor, Barretos, Not set
CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina, Florianópolis, Not set
Oncosite - Centro de Pesquisa Clinica Em Oncologia, Ijuí, Not set
Centro Gaucho Integrado de Oncologia, Hematologia, Ensino e Pesquisa, Porto Alegre, Not set
Hospital Sao Lucas - Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS), Porto Alegre, Not set
Hospital Alemao Oswaldo Cruz, São Paulo, Not set
Hospital A.C. Camargo Cancer Center, São Paulo, Not set
British Columbia Cancer Agency- Centre for the Southern Interior, Kelowna, Not set
McGill University Health Center, Québec, Not set
Princess Margaret Hospital, Toronto, Not set
Cancer Care Manitoba, Winnipeg, Not set
Fundación Arturo López Pérez (FALP), Santiago, Not set
Centro de Investigacion Clinica Bradford Hill, Santiago, Not set
Oncocentro APYS, Viña Del Mar, Not set
Aalborg University Hospital, Aalborg, Not set
Service d'Oncologie Medicale - CHRU Besancon, Besançon, Not set
Institut Bergonie, Bordeaux Cedex, Not set
CHU Bordeaux - Hopital Saint-Andre, Bordeaux, Not set
Groupement de Cooperation Sanitaire (GCS) ELSAN - Clinique Victor Hugo, Le Mans, Not set
CHU de Limoges - Hopital Dupuytren 1, Limoges, Not set
Centre Leon Berard, Lyon, Not set
Institut Paoli-Calmettes, Marseille, Not set
ICM - Institut Regional du Cancer de Montpellier, Montpellier Cedex 5, Not set
Centre d'Oncologie de Gentilly, Nancy, Not set
Centre Antoine-Lacassagne, Nice, Not set
Institut Mutualiste Montsouris, Paris, Not set
AP-HP Hopital Europeen Georges Pompidou, Paris, Not set
HCL Centre Hospitalier Lyon Sud, Pierre-Benite Cedex, Not set
CHU Poitiers - Pole Regional de Cancerologie de Poitiers (PRC), Poitiers, Not set
Institut Gustave Roussy, Villejuif, Not set
LTD High Technology Hospital Medcenter, Batumi, Not set
The First University Clinic of Tbilisi State Medical University, Tbilisi, Not set
New Vision University Hospital, Tbilisi, Not set
Multiprofile Clinic Consilium Medulla LTD, Tbilisi, Not set
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden, Not set
Universitaetsklinikum Essen, Essen, Not set
Krankenhaus Nordwest GmbH, Frankfurt, Not set
Universitaetsklinikum Frankfurt - Klinikum der Johann Wolfgang Goethe Universitaet, Frankfurt, Not set
Universitaetsklinikum Freiburg, Freiburg, Not set
Georg-August-Universitaet Goettingen Stiftung oeffentlichen Rechts Universitaetsmedizin Goettingen, Göttingen, Not set
Marien Hospital Herne - Universitaetsklinikum der Ruhr-Universitaet Bochum, Herne, Not set
Universitaetsmedizin Mannheim, Mannheim, Not set
Universitaetsklinikum Muenster, Münster, Not set
Studienpraxis Urologie, Nürtingen, Not set
Universitaetsklinikum Tuebingen, Tübingen, Not set
Orszagos Onkologiai Intezet, Budapest, Not set
Budapesti Uzsoki Utcai Korhaz, Budapest, Not set
Somogy Varmegyei Kaposi Mor Oktato Korhaz, Kaposvár, Not set
Bacs-Kiskun Varmegyei Oktatokorhaz, Kecskemét, Not set
Shamir Medical Center, Be'er Ya'aqov, Not set
Rambam Health Care Campus, Haifa, Not set
Hadassah Hebrew University Medical Center, Jerusalem, Not set
Meir Medical Center, Kfar Saba, Not set
Rabin Medical Center - Beilinson Hospital, Petach Tikva, Not set
Sourasky Medical Center, Tel Aviv, Not set
Centro Riferimento Oncologico - Aviano, Aviano, Not set
Ospedale Policlinico San Martino IRCCS, Genova, Not set
Istituto Europeo di Oncologia, Milano, Not set
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Not set
Azienda Ospedaliera Santa Maria di Terni, Terni, Not set
Chungnam National University Hospital, Daejeon, Not set
National Cancer Center, Goyang, Not set
Chonnam National University Hwasun Hospital, Gwangju, Not set
Korea University Anam Hospital, Seoul, Not set
Seoul National University Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Samsung Medical Center, Seoul, Not set
Severance Hospital, Yonsei University Health System, Seoul, Not set
Copernicus PL Sp. z o.o., Wojewodzkie Centrum Onkologii, Gdańsk, Not set
Spitale Pomorskie Sp.z.o.o ODDZIAL ONKOLOGII KLINICZNEJ, Gdynia, Not set
SCM Sp. z o.o., Kraków, Not set
Mazowiecki Szpital Onkologiczny, Wieliszew, Not set
University Clinical Center of Serbia, Clinic of Urology, Belgrade, Not set
National University Hospital, Singapore, Not set
National Cancer Centre Singapore, Singapore, Not set
Hospital de la Santa Creu i Sant Pau, Barcelona, Not set
Hospital Clinic Barcelona, Barcelona, Not set
Institut Catala d'Oncologia - L'Hospitalet, Barcelona, Not set
Hospital Universitario Insular de Gran Canaria, Las Palmas De Gran Canaria, Not set
Hospital General Universitario Gregorio Maranon, Madrid, Not set
Clinica Universidad de Navarra - Madrid, Madrid, Not set
Hospital Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario La Paz, Madrid, Not set
Clinica Universidad de Navarra - Pamplona, Pamplona, Not set
Hospital Universitario Donostia, San Sebastián, Not set
Hospital Universitario Marques de Valdecilla, Santander, Not set
Hospital Clinico Universitario de Santiago, Santiago De Compostela, Not set
Instituto Valenciano de Oncologia, Valencia, Not set
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Not set
China Medical University Hospital, Taichung, Not set
National Cheng Kung University Hospital, Tainan, Not set
Chi Mei Medical Center, Tainan, Not set
National Taiwan University Hospital, Taipei, Not set
Linkou Chang Gung Memorial Hospital (CGMHLK), Taoyuan city, Not set
Liv Hospital Ankara, Ankara, Not set
Trakya University Medical Faculty, Edirne, Not set
Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Not set
Istinye Universitesi VM Medical Park Pendik Hastanesi, Istanbul, Not set
Medical Point Izmir Hospital, İzmir, Not set
Kocaeli University Faculty of Medicine, Kocaeli, Not set
Bristol Haematology and Oncology Centre, Bristol, Not set
Addenbrooke's Hospital, Cambridge, Not set
St. Bartholomew's Hospital, London, Not set
University College London Hospital, London, Not set
Royal Free London NHS Foundation Trust, London, Not set
Charing Cross Hospital, London, Not set
The Christie NHS Foundation Trust, Manchester, Not set
Derriford Hospital, Plymouth, Not set
The Royal Marsden Hospital, Sutton, Not set
Conditions: Metastatic Urothelial Cancer
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Recruiting
A prospective, open-label, multi-cohort, non-randomized, multicenter Phase 2 study evaluating adoptive cell therapy (ACT) with TIL \[LN-144/LN-145 (lifileucel)\] in combination with immune checkpoint inhibitors or TIL \[LN-144/LN-145 (lifileucel) and LN-145-S1\] as a single agent therapy.
A prospective, open-label, multi-cohort, non-randomized, multicenter Phase 2 study evaluating adoptive cell therapy (ACT) with TIL \[LN-144/LN-145 (lifileucel)\] in combination with immune checkpoint inhibitors or TIL \[LN-144/LN-145 (lifileucel) and LN-145-S1\] as a single agent therapy. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/18/2025
Locations: University of California, San Diego, La Jolla, California +44 locations
University of California, San Diego, La Jolla, California
University of Southern California, Los Angeles, California
University of California, Los Angeles, Los Angeles, California
University of Colorado, Denver, Colorado
Yale University, New Haven, Connecticut
Georgetown University Medical Center, Washington, District of Columbia
Mount Sinai Medical Center, Miami Beach, Florida
Orlando Health Cancer Institute, Orlando, Florida
Moffitt Cancer Center, Tampa, Florida
University of Louisville, Louisville, Kentucky
University of Maryland, Baltimore, Maryland
Massachusetts General Hospital, Boston, Massachusetts
Karmanos Cancer Institute, Detroit, Michigan
Henry Ford Health System, Detroit, Michigan
MD Anderson at Cooper, Camden, New Jersey
Morristown Medical Center, Morristown, New Jersey
Columbia University, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
University of Cincinnati, Cincinnati, Ohio
Ohio State University, Columbus, Ohio
Avera Cancer Institute, Sioux Falls, South Dakota
Huntsman Cancer Hospital, Salt Lake City, Utah
Fred Hutchinson Cancer Research Center, Seattle, Washington
Medical College of Wisconsin, Milwaukee, Wisconsin
Princess Margaret Cancer Centre, Toronto, Ontario
Centre Léon Berard, Lyon, Not set
Klinikum rechts der Isar der Technischen Universität München, München, Bavaria
Universitätsklinikum Carl Gustav Carus, Dresden, Sachsen
Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein
Laiko General Hospital of Athens, Athens, Attiki
Attikon University General Hospital, Athens, Attiki
Hospital Universitario Marques de Valdecilla, Santander, Cantabria
University Hospital Vall d'Hebron, Barcelona, Not set
ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Not set
Hospital General Universitario Gregorio Marañón, Madrid, Not set
Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Hospital Universitario HM Sanchinarro, Madrid, Not set
Hospital Regional Universitario de Malaga - Hospital General, Málaga, Not set
Universitätsspital Basel, Basel, Not set
Universitaetsspital Bern, Bern, Not set
Centre Hospitalier Universitaire Vaudois, Lausanne, Not set
Guy's Hospital, London, England
The Royal Marsden NHS Foundation Trust, London, England
Bristol Haematology and Oncology Centre, Bristol, Not set
Conditions: Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck, Non-small Cell Lung Cancer
Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC
Active Not Recruiting
A Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment and Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder Cancer
A Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment and Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder Cancer Read Less
Gender:
ALL
Ages:
Between 18 years and 130 years
Trial Updated:
06/17/2025
Locations: Research Site, Birmingham, Alabama +187 locations
Research Site, Birmingham, Alabama
Research Site, Los Angeles, California
Research Site, Palo Alto, California
Research Site, New Haven, Connecticut
Research Site, Chicago, Illinois
Research Site, Geneva, Illinois
Research Site, Iowa City, Iowa
Research Site, Westwood, Kansas
Research Site, Louisville, Kentucky
Research Site, New Orleans, Louisiana
Research Site, Towson, Maryland
Research Site, Ann Arbor, Michigan
Research Site, Detroit, Michigan
Research Site, New York, New York
Research Site, Rochester, New York
Research Site, Bethlehem, Pennsylvania
Research Site, Burlington, Vermont
Research Site, Milwaukee, Wisconsin
Research Site, Brisbane, Not set
Research Site, Elizabeth Vale, Not set
Research Site, Macquarie University, Not set
Research Site, Melbourne, Not set
Research Site, Murdoch, Not set
Research Site, South Brisbane, Not set
Research Site, Brugge, Not set
Research Site, Charleroi, Not set
Research Site, Kortrijk, Not set
Research Site, Leuven, Not set
Research Site, Liège, Not set
Research Site, Roeselare, Not set
Research Site, Barretos, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Porto Alegre, Not set
Research Site, Rio de Janeiro, Not set
Research Site, Santa Maria, Not set
Research Site, Sao Paulo, Not set
Research Site, Sao Paulo, Not set
Research Site, São José do Rio Preto, Not set
Research Site, São Paulo, Not set
Research Site, São Paulo, Not set
Research Site, Edmonton, Alberta
Research Site, Vancouver, British Columbia
Research Site, London, Ontario
Research Site, Ottawa, Ontario
Research Site, Toronto, Ontario
Research Site, Montreal, Quebec
Research Site, Sherbrooke, Quebec
Research Site, Antofagasta, Not set
Research Site, Puerto Montt, Not set
Research Site, Santiago, Not set
Research Site, Temuco, Not set
Research Site, Temuco, Not set
Research Site, Viña del Mar, Not set
Research Site, Brno, Not set
Research Site, Brno, Not set
Research Site, Hradec Kralove, Not set
Research Site, Olomouc, Not set
Research Site, Praha 2, Not set
Research Site, Praha 8, Not set
Research Site, Praha, Not set
Research Site, Angers Cedex 01, Not set
Research Site, Dijon, Not set
Research Site, Grenoble Cedex 09, Not set
Research Site, Montpellier, Not set
Research Site, Nimes, Not set
Research Site, Pierre Benite, Not set
Research Site, Poitiers Cedex, Not set
Research Site, Rouen, Not set
Research Site, Bergisch Gladbach, Not set
Research Site, Bonn, Not set
Research Site, Erlangen, Not set
Research Site, Göttingen, Not set
Research Site, Herne, Not set
Research Site, Jena, Not set
Research Site, Köln, Not set
Research Site, Magdeburg, Not set
Research Site, Mannheim, Not set
Research Site, Münster, Not set
Research Site, Nürnberg, Not set
Research Site, Oldenburg, Not set
Research Site, Regensburg, Not set
Research Site, Ulm, Not set
Research Site, Würzburg, Not set
Research Site, Haifa, Not set
Research Site, Jerusalem, Not set
Research Site, Kfar Saba, Not set
Research Site, Petach-Tikva, Not set
Research Site, Ramat Gan, Not set
Research Site, Bari, Not set
Research Site, Bologna, Not set
Research Site, Firenze, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Napoli, Not set
Research Site, Orbassano, Not set
Research Site, Pozzuoli, Not set
Research Site, Verona, Not set
Research Site, Bunkyo-ku, Not set
Research Site, Fukuoka-shi, Not set
Research Site, Fukuoka, Not set
Research Site, Hirosaki-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Kanazawa-shi, Not set
Research Site, Koto-ku, Not set
Research Site, Kumamoto-shi, Not set
Research Site, Miyazaki-city, Not set
Research Site, Nagasaki-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osakasayama-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Toyama-shi, Not set
Research Site, Tsukuba-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Daegu, Not set
Research Site, Goyang-si, Not set
Research Site, Gyeonggi-do, Not set
Research Site, Incheon, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Amsterdam, Not set
Research Site, Amsterdam, Not set
Research Site, Breda, Not set
Research Site, Rotterdam, Not set
Research Site, Baguio City, Not set
Research Site, Cebu, Not set
Research Site, Davao City, Not set
Research Site, Makati, Not set
Research Site, Manila, Not set
Research Site, Quezon City, Not set
Research Site, Quezon City, Not set
Research Site, Bialystok, Not set
Research Site, Gdańsk, Not set
Research Site, Grudziądz, Not set
Research Site, Koszalin, Not set
Research Site, Kraków, Not set
Research Site, Olsztyn, Not set
Research Site, Ostrołęka, Not set
Research Site, Poznan, Not set
Research Site, Warszawa, Not set
Research Site, Wroclaw, Not set
Research Site, Krasnoyarsk, Not set
Research Site, Moscow, Not set
Research Site, Nizhniy Novgorod, Not set
Research Site, Novosibirsk, Not set
Research Site, Samara, Not set
Research Site, St Petersburg, Not set
Research Site, St. Petersburg, Not set
Research Site, St. Petersburg, Not set
Research Site, St. Petersburg, Not set
Research Site, Ufa, Not set
Research Site, Vologda, Not set
Research Site, Badalona, Not set
Research Site, Barcelona, Not set
Research Site, Córdoba, Not set
Research Site, Las Palmas de Gran Canaria, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Santander, Not set
Research Site, Sevilla, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Taichung, Not set
Research Site, Tainan, Not set
Research Site, Tainan, Not set
Research Site, Taipei City, Not set
Research Site, Taipei, Not set
Research Site, Taoyuan City, Not set
Research Site, Ankara, Not set
Research Site, Edirne, Not set
Research Site, Istanbul, Not set
Research Site, İstanbul, Not set
Research Site, Izmir, Not set
Research Site, Karsiyaka, Not set
Research Site, Edinburgh, Not set
Research Site, London, Not set
Research Site, Nottingham, Not set
Research Site, Sheffield, Not set
Research Site, Wirral, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Hochiminh, Not set
Conditions: Muscle Invasive Bladder Cancer
Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Completed
This is a pilot study to determine the overall survival rate and toxicities of obinutuzumab given with GDP chemotherapy for relapsed or refractory CD20+ aggressive non-Hodgkin lymphoma. Patients who have CD20+ and progressed R-CHOP therapy will be enrolled into the study. About 30 patients are planned to be enrolled from Princess Margaret Cancer Centre.
If the enrollment is very slow then additional site may be included. Patients will receive Obinutuzumab +GDP for 3 cycles intravenously. CT sca... Read More
This is a pilot study to determine the overall survival rate and toxicities of obinutuzumab given with GDP chemotherapy for relapsed or refractory CD20+ aggressive non-Hodgkin lymphoma. Patients who have CD20+ and progressed R-CHOP therapy will be enrolled into the study. About 30 patients are planned to be enrolled from Princess Margaret Cancer Centre.
If the enrollment is very slow then additional site may be included. Patients will receive Obinutuzumab +GDP for 3 cycles intravenously. CT scan will be used to evaluate the response rate after cycle 2 and PET-CT will be used after cycle 3. Responders (complete metabolic response, partial metabolic response) should proceed to autologous stem cell transplant (ASCT). Patients who have progressed after three cycles or less are to have their protocol treatment discontinued, with subsequent treatment at investigator discretion. Patients will be followed up to 24 months from transplant done or last chemo. Mandatory tissue submission and optional tissue and blood submission are required for the correlative component of this study. Read Less
Gender:
ALL
Ages:
Between 16 years and 70 years
Trial Updated:
06/17/2025
Locations: Princess Margaret Cancer Centre, Toronto, Ontario
Princess Margaret Cancer Centre, Toronto, Ontario
Conditions: Lymphoma, Non-Hodgkin's
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
Active Not Recruiting
This is a phase 2/3, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in combination in participants with unresectable, advanced or metastatic NSCLC determined to harbor oncogenic somatic mutations or positive by tumor mutational burden (TMB) assay as identified by a blood-based next-generation sequencing (NGS) circulating tumor DNA (ctDNA) assay.
This is a phase 2/3, global, multicenter, open-label, multi-cohort study designed to evaluate the safety and efficacy of targeted therapies or immunotherapy as single agents or in combination in participants with unresectable, advanced or metastatic NSCLC determined to harbor oncogenic somatic mutations or positive by tumor mutational burden (TMB) assay as identified by a blood-based next-generation sequencing (NGS) circulating tumor DNA (ctDNA) assay. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/11/2025
Locations: UC Davis, Sacramento, California +157 locations
UC Davis, Sacramento, California
Rocky Mountain Cancer Center, Denver, Colorado
SCRI Florida Cancer Specialists South, Fort Myers, Florida
Florida Cancer Specialist, North Region, Saint Petersburg, Florida
University of Kentucky, Lexington, Kentucky
Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire
Montefiore Medical Center, Bronx, New York
Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York
Oregon HSU, Portland, Oregon
St. Luke's University Health network, Bethlehem, Pennsylvania
Sarah Cannon Research Institute / Tennessee Oncology, Chattanooga, Tennessee
Sarah Cannon Research Institute / Tennessee Oncology, Nashville, Tennessee
Fundación CENIT para la Investigación en Neurociencias, Buenos Aires, Not set
Hospital Italiano, Buenos Aires, Not set
Hospital Britanico de Buenos Aires, Ciudad Autonoma Buenos Aires, Not set
Royal North Shore Hospital, St Leonards, New South Wales
The Prince Charles Hospital, Chermside, Queensland
Ashford Cancer Center Research, Kurralta Park, South Australia
UZ Brussel, Brussel, Not set
UZ Leuven Gasthuisberg, Leuven, Not set
Oncosite - Centro de Pesquisa Clinica Em Oncologia Ltda, Ijui, Rio Grande Do Sul
Hospital Sao Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul
Instituto do Cancer do Estado de Sao Paulo - ICESP, Sao Paulo, São Paulo
Cross Cancer Institute, Edmonton, Alberta
CancerCare Manitoba, Winnipeg, Manitoba
Royal Victoria Regional Health Centre, Barrie, Ontario
William Osler Health System Brampton Civic Hospital, Brampton, Ontario
London Health Sciences Centre · Victoria Hospital, London, Ontario
Lakeridge Health Center, Oshawa, Ontario
Sunnybrook Health Sciences Centre, Toronto, Ontario
Princess Margaret Cancer Center, Toronto, Ontario
Jewish General Hospital, Montreal, Quebec
IUCPQ (Hôpital Laval), Quebec City, Quebec
Saskatoon Cancer Centre, Saskatoon, Saskatchewan
Bradford Hill Centro de Investigaciones Clinicas, Recoleta, Not set
Beijing Cancer Hospital, Beijing, Not set
Jilin Cancer Hospital, Changchun, Not set
Hunan Cancer Hospital, Changsha City, Not set
The second Xiangya hospital of central south university, Changsha City, Not set
Sichuan Cancer Hospital, Chengdu City, Not set
West China Hospital - Sichuan University, Chengdu City, Not set
The First Affiliated Hospital of Guangzhou Medical University Pharmacy, Guangzhou, Not set
Zhejiang Cancer Hospital, Hangzhou City, Not set
Shandong Cancer Hospital, Jinan, Not set
The Second Affiliated Hospital to Nanchang University, Nanchang, Not set
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing City, Not set
Fudan Unviversity Shanghai Cancer Center, Shanghai, Not set
First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Not set
Centre Oscar Lambret, Lille, Not set
Centre Léon Bérard, Lyon, Not set
Hopital Caremeau, Nimes, Not set
Hôpital Européen Georges Pompidou, Paris, Not set
Hopital Tenon, Paris, Not set
CHU Poitiers, Poitiers, Not set
Hopital Pontchaillou, Rennes, Not set
CHU de Toulouse - Hôpital Larrey, Toulouse Cedex 9, Not set
Klinikum Chemnitz gGmbH, Chemnitz, Not set
Asklepios-Fachklinik Muenchen-Gauting, Gauting, Not set
Thoraxklinik Heidelberg gGmbH, Heidelberg, Not set
HSK Dr.-Horst-Schmidt-Kliniken Klinik für Innere Medizin III Onkologie Hämatologie und Palliativmed, Wiesbaden, Not set
Queen Mary Hospital, Hong Kong, Not set
Prince of Wales Hosp, Shatin, Not set
Soroka Medical Center, Beer Sheva, Not set
Rambam Health Care Campus, Haifa, Not set
Meir Medical Center, Kfar-Saba, Not set
Rabin MC, Petach Tikva, Not set
Chaim Sheba Medical Center, Ramat Gan, Not set
Sourasky / Ichilov Hospital; Dept. of Oncology, Tel Aviv, Not set
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Napoli, Campania
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola, Emilia-Romagna
Irccs Centro Di Riferimento Oncologico (CRO), Aviano, Friuli-Venezia Giulia
Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio
Asst Papa Giovanni XXIII, Bergamo, Lombardia
ASST di Cremona - Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Lombardia
Irccs Istituto Europeo di Oncologia (IEO), Milano, Lombardia
Asst Di Monza, Monza, Lombardia
Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano (TO), Piemonte
Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Bunkyo-ku, Not set
National Hospital Organization Kyushu Medical Center, Fukuoka, Not set
National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set
Kyushu University Hospital, Fukuoka, Not set
Hiroshima University Hospital, Hiroshima, Not set
Kanazawa University Hospital, Ishikawa, Not set
Kanagawa Cancer Center, Kanagawa, Not set
University Hospital Kyoto Prefectural University of Medicine, Kyoto, Not set
Shikoku Cancer Center, Matsuyama-shi, Not set
Tohoku University Hospital, Miyagi, Not set
Sendai Kousei Hospital, Miyagi, Not set
Niigata Cancer Center Hospital, Niigata-shi, Not set
Niigata University Medical & Dental Hospital, Niigata, Not set
Kindai University Hospital, Osaka, Not set
Saga University Hospital, Saga, Not set
Shizuoka Cancer Center, Shizuoka, Not set
Juntendo University Hospital, Tokyo, Not set
The Cancer Institute Hospital of JFCR, Tokyo, Not set
Kyorin University Hospital, Tokyo, Not set
Fujita Health University Hospital, Toyoake-shi, Not set
Wakayama Medical University Hospital, Wakayama, Not set
National Hospital Organization Yamaguchi - Ube Medical Center, Yamaguchi, Not set
National Cancer Center, Gyeonggi-do, Not set
Chonnam National University Hwasun Hospital, Jeollanam-do, Not set
Seoul National University Hospital, Seoul, Not set
Asan Medical Center, Seoul, Not set
Yonsei University Health System/Severance Hospital, Seoul, Not set
Hospital Angeles Tijuana, Tijuana, BAJA California
Health Pharma Professional Research, Cdmx, Mexico CITY (federal District)
AVIX Investigación Clínica S.C, Monterrey, Nuevo LEON
Oncologico Potosino, San Luis Potosí, SAN LUIS Potosi
Auckland City Hospital, Auckland, Not set
Hemato Oncología de Panamá Especializada, Panama City, Not set
Hospital Nacional Edgardo Rebagliati Martins, Lima, Not set
Instituto Nacional de Enfermedades Neoplasicas, Lima, Not set
Instituto Peruano de Oncología y Radioterapia, Lima, Not set
Clinica Ricardo Palma, San Isidro, Not set
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie, Olsztyn, Not set
Mazowieckie Centrum Leczenia Chorob Pluc I Gruzlicy, Otwock, Not set
Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu, Poznan, Not set
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad, Warszawa, Not set
Moscow City Oncology Hospital #62, Moscovskaya Oblast, Moskovskaja Oblast
S-Pb clinical scientific practical center of specialized kinds of medical care (oncological), Saint-Petersburg, Sankt Petersburg
Clinical Oncology Dispensary, Omsk, Not set
Clinical Center of Serbia, Belgrade, Not set
University Hospital Medical Center Bezanijska kosa, Belgrade, Not set
Clinical Center Nis, NIS, Not set
National University Hospital, Singapore, Not set
National Cancer Centre, Singapore, Not set
Insititut Catala D'Oncologia, Hospitalet de Llobregat, Barcelona
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, LA Coruna
Clinica Universitaria de Navarra, Pamplona, Navarra
Hospital General Univ. de Alicante, Alicante, Not set
Hospital Universitari Vall d'Hebron, Barcelona, Not set
Hospital Clínic i Provincial, Barcelona, Not set
ICO Badalona - Hospital Germans Trias i Pujol, Barcelona, Not set
Hospital General Universitario Gregorio Marañon, Madrid, Not set
Hospital Ramon y Cajal, Madrid, Not set
Hospital Universitario 12 de Octubre, Madrid, Not set
Centro Integral Oncologico Clara Campal, Madrid, Not set
Hospital Universitario Puerta de Hierro, Madrid, Not set
Hospital Quiron de Madrid, Madrid, Not set
Hospital Regional Universitario Carlos Haya, Malaga, Not set
Hospital Universitario Virgen del Rocio, Sevilla, Not set
Hospital Clínico Universitario de Valencia, Valencia, Not set
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Not set
National Taiwan Uni Hospital, Taipei, Not set
Taipei Veterans General Hospital, Taipei, Not set
Chang Gung Medical Foundation - Linkou, Taoyuan, Not set
Chulalongkorn Hospital, Bangkok, Not set
Ramathibodi Hospital, Bangkok, Not set
Faculty of Med. Siriraj Hosp., Bangkok, Not set
Prince of Songkla University, Hat Yai, Not set
Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital; Medical Oncology, Adana, Not set
Akdeniz University Medical Faculty; Medical Oncology Department, Antalya, Not set
Trakya University Medical Faculty Research And Practice Hospital Medical Oncology Department, Edirne, Not set
Medipol University Medical Faculty; Oncology Department, Istanbul, Not set
Marmara University Pendik Training and Research Hospital; Medikal Onkoloji, Istanbul, Not set
Medikal Park Izmir Hospital, Kar??yaka, Not set
Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Sihhiye/Ankara, Not set
Conditions: Non-Small Cell Lung Cancer
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
Recruiting
This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.
This study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer. Read Less
Gender:
ALL
Ages:
12 years and above
Trial Updated:
06/11/2025
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas +9 locations
University of Arkansas for Medical Sciences, Little Rock, Arkansas
University of California, Irvine, Irvine, California
University of California, San Francisco, San Francisco, California
Emory Winship Cancer Institute, Atlanta, Georgia
Boston Medical Center, Boston, Massachusetts
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York
University of Cincinnati Medical Center, Cincinnati, Ohio
Cleveland Clinic, Cleveland, Ohio
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin
Princess Margaret Cancer Centre, Toronto, Not set
Conditions: Nasopharyngeal Cancer Recurrent
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer
Active Not Recruiting
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of pathological complete response.
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of pathological complete response. Read Less
Gender:
ALL
Ages:
Between 18 years and 120 years
Trial Updated:
06/10/2025
Locations: Research Site, Phoenix, Arizona +230 locations
Research Site, Phoenix, Arizona
Research Site, Duarte, California
Research Site, Orange, California
Research Site, Aurora, Colorado
Research Site, Boca Raton, Florida
Research Site, Jacksonville, Florida
Research Site, Chicago, Illinois
Research Site, Wichita, Kansas
Research Site, Ashland, Kentucky
Research Site, Lexington, Kentucky
Research Site, Silver Spring, Maryland
Research Site, Towson, Maryland
Research Site, Duluth, Minnesota
Research Site, Minneapolis, Minnesota
Research Site, Morristown, New Jersey
Research Site, New York, New York
Research Site, New York, New York
Research Site, Shirley, New York
Research Site, Durham, North Carolina
Research Site, Bend, Oregon
Research Site, Medford, Oregon
Research Site, Pittsburgh, Pennsylvania
Research Site, Charleston, South Carolina
Research Site, Charleston, South Carolina
Research Site, Austin, Texas
Research Site, Fort Worth, Texas
Research Site, Houston, Texas
Research Site, Houston, Texas
Research Site, Fairfax, Virginia
Research Site, Kirkland, Washington
Research Site, Seattle, Washington
Research Site, Buenos Aires, Not set
Research Site, Caba, Not set
Research Site, Caba, Not set
Research Site, La Plata, Not set
Research Site, Pergamino, Not set
Research Site, Rosario, Not set
Research Site, San Salvador de Jujuy, Not set
Research Site, Viedma, Not set
Research Site, Graz, Not set
Research Site, Innsbruck, Not set
Research Site, Rankweil, Not set
Research Site, Wien, Not set
Research Site, Wien, Not set
Research Site, Gent, Not set
Research Site, Liège, Not set
Research Site, Mons, Not set
Research Site, Barretos, Not set
Research Site, Belo Horizonte, Not set
Research Site, Campinas, Not set
Research Site, Curitiba, Not set
Research Site, Florianópolis, Not set
Research Site, Natal, Not set
Research Site, Porto Alegre, Not set
Research Site, Santa Maria, Not set
Research Site, Sao Paulo, Not set
Research Site, São José do Rio Preto, Not set
Research Site, São Paulo, Not set
Research Site, Teresina, Not set
Research Site, Vitoria, Not set
Research Site, Plovdiv, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Sofia, Not set
Research Site, Edmonton, Alberta
Research Site, Kitchener, Ontario
Research Site, Levis, Quebec
Research Site, Montreal, Quebec
Research Site, Montreal, Quebec
Research Site, Saskatoon, Saskatchewan
Research Site, Quebec, Not set
Research Site, Santiago, Not set
Research Site, Santiago, Not set
Research Site, Temuco, Not set
Research Site, Viña del Mar, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Beijing, Not set
Research Site, Changsha, Not set
Research Site, Changsha, Not set
Research Site, Changzhou, Not set
Research Site, Chengdu, Not set
Research Site, Guangzhou, Not set
Research Site, Guangzhou, Not set
Research Site, Guiyang, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hangzhou, Not set
Research Site, Hefei, Not set
Research Site, Kunming, Not set
Research Site, Linhai, Not set
Research Site, Nanchang, Not set
Research Site, Ningbo, Not set
Research Site, Shanghai, Not set
Research Site, Shanghai, Not set
Research Site, Shenyang, Not set
Research Site, Shenyang, Not set
Research Site, Shenzhen, Not set
Research Site, Shenzhen, Not set
Research Site, Tianjin, Not set
Research Site, Urumqi, Not set
Research Site, Wuhan, Not set
Research Site, Wuhan, Not set
Research Site, Xiamen, Not set
Research Site, Xintai, Not set
Research Site, Yangzhou, Not set
Research Site, Zhengzhou, Not set
Research Site, San José, Not set
Research Site, San José, Not set
Research Site, Avignon Cedex, Not set
Research Site, Lyon Cedex 08, Not set
Research Site, Nice, Not set
Research Site, Toulon Cedex 9, Not set
Research Site, Vantoux, Not set
Research Site, Bielefeld, Not set
Research Site, Frankfurt am Main, Not set
Research Site, Immenstadt, Not set
Research Site, Köln, Not set
Research Site, Budapest, Not set
Research Site, Gyöngyös - Mátraháza, Not set
Research Site, Győr, Not set
Research Site, Székesfehérvár, Not set
Research Site, Törökbálint, Not set
Research Site, Ahmedabad, Not set
Research Site, Gurgaon, Not set
Research Site, Gurgaon, Not set
Research Site, Kolkata, Not set
Research Site, Manipal, Not set
Research Site, Mumbai, Not set
Research Site, Mumbai, Not set
Research Site, Mysuru, Not set
Research Site, Namakkal, Not set
Research Site, Nashik, Not set
Research Site, New Delhi, Not set
Research Site, New Delhi, Not set
Research Site, Thane, Not set
Research Site, Vishakhapatnam, Not set
Research Site, Ancona, Not set
Research Site, Bari, Not set
Research Site, Bergamo, Not set
Research Site, Firenze, Not set
Research Site, Milano, Not set
Research Site, Monza, Not set
Research Site, Padova, Not set
Research Site, Roma, Not set
Research Site, Verona, Not set
Research Site, Habikino-shi, Not set
Research Site, Himeji-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Hiroshima-shi, Not set
Research Site, Iwakuni-shi, Not set
Research Site, Kitaadachi-gun, Not set
Research Site, Kitakyushu-shi, Not set
Research Site, Kurashiki shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Niigata-shi, Not set
Research Site, Okayama-shi, Not set
Research Site, Osakasayama-shi, Not set
Research Site, Toyoake-shi, Not set
Research Site, Wakayama-shi, Not set
Research Site, Busan, Not set
Research Site, Cheongju-si, Not set
Research Site, Seongnam-si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Suwon, Not set
Research Site, Aguascalientes, Not set
Research Site, Chihuahua, Not set
Research Site, Guadalajara, Not set
Research Site, Monterrey, Not set
Research Site, Monterrey, Not set
Research Site, México, Not set
Research Site, México, Not set
Research Site, Pachuca de Soto, Not set
Research Site, Arnhem, Not set
Research Site, Nijmegen, Not set
Research Site, Bellavista, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Lima, Not set
Research Site, Davao City, Not set
Research Site, Iloilo City, Not set
Research Site, Makati, Not set
Research Site, Quezon City, Not set
Research Site, Białystok, Not set
Research Site, Olsztyn, Not set
Research Site, Warszawa, Not set
Research Site, Warszawa, Not set
Research Site, Suceava, Not set
Research Site, Kazan, Not set
Research Site, Krasnoyarsk, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Nizhniy Novgorod, Not set
Research Site, Obninsk, Not set
Research Site, Rostov-on-Don, Not set
Research Site, St. Petersburg, Not set
Research Site, Tomsk, Not set
Research Site, Yaroslavl, Not set
Research Site, Alicante, Not set
Research Site, Barcelona, Not set
Research Site, Madrid, Not set
Research Site, Málaga, Not set
Research Site, Oviedo, Not set
Research Site, Pamplona, Not set
Research Site, San Sebastian, Not set
Research Site, Santiago De Compostela (A Coruña), Not set
Research Site, Changhua, Not set
Research Site, Taichung City, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Tainan City, Not set
Research Site, Taipei City, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Bangkok, Not set
Research Site, Bangkok, Not set
Research Site, Chiang Mai, Not set
Research Site, Chiang Rai, Not set
Research Site, Khon Kaen, Not set
Research Site, Lampang, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Ho Chi Minh, Not set
Conditions: Non-Small Cell Lung Cancer
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Active Not Recruiting
This phase I trial identifies the best dose, possible benefits and/or side effects of BAY 1895344 in combination with chemotherapy in treating patients with solid tumors or urothelial cancer that has spread to other places in the body (advanced). BAY 1895344 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cisplatin and gemcitabine are chemotherapy drugs that stop the growth of tumor cells by killing the cells. Combining BAY 1895344 with chemotherapy tre... Read More
This phase I trial identifies the best dose, possible benefits and/or side effects of BAY 1895344 in combination with chemotherapy in treating patients with solid tumors or urothelial cancer that has spread to other places in the body (advanced). BAY 1895344 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Cisplatin and gemcitabine are chemotherapy drugs that stop the growth of tumor cells by killing the cells. Combining BAY 1895344 with chemotherapy treatment (cisplatin, or cisplatin and gemcitabine) may be effective for the treatment of advanced solid tumors, including urothelial cancer. Read Less
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/07/2025
Locations: University of California Davis Comprehensive Cancer Center, Sacramento, California +7 locations
University of California Davis Comprehensive Cancer Center, Sacramento, California
National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland
National Institutes of Health Clinical Center, Bethesda, Maryland
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Ohio State University Comprehensive Cancer Center, Columbus, Ohio
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
University Health Network-Princess Margaret Hospital, Toronto, Ontario
Conditions: Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Gastric Carcinoma, Advanced Head and Neck Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Penile Carcinoma, Advanced Pleural Malignant Mesothelioma, Advanced Urothelial Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Distal Bile Duct Cancer AJCC v8, Stage III Intrahepatic Bile Duct Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Penile Cancer AJCC v8, Stage III Pleural Malignant Mesothelioma AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Distal Bile Duct Cancer AJCC v8, Stage IV Intrahepatic Bile Duct Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Penile Cancer AJCC v8, Stage IV Pleural Malignant Mesothelioma AJCC v8, Triple-Negative Breast Carcinoma, Unresectable Urothelial Carcinoma
Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)
Active Not Recruiting
This is a randomized, open-label, multi-center, global, Phase III study to determine the efficacy and safety of MEDI4736 + tremelimumab combination therapy and MEDI4736 monotherapy versus platinum-based SoC chemotherapy in the first-line treatment of patients with epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) wild-type locally advanced or metastatic NSCLC
This is a randomized, open-label, multi-center, global, Phase III study to determine the efficacy and safety of MEDI4736 + tremelimumab combination therapy and MEDI4736 monotherapy versus platinum-based SoC chemotherapy in the first-line treatment of patients with epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) wild-type locally advanced or metastatic NSCLC Read Less
Gender:
ALL
Ages:
Between 18 years and 130 years
Trial Updated:
06/06/2025
Locations: Research Site, Scottsdale, Arizona +198 locations
Research Site, Scottsdale, Arizona
Research Site, Tucson, Arizona
Research Site, Yuma, Arizona
Research Site, Bakersfield, California
Research Site, Fullerton, California
Research Site, La Jolla, California
Research Site, Los Angeles, California
Research Site, Los Angeles, California
Research Site, Redondo Beach, California
Research Site, Sacramento, California
Research Site, San Luis Obispo, California
Research Site, Santa Maria, California
Research Site, West Hollywood, California
Research Site, New Haven, Connecticut
Research Site, Jacksonville, Florida
Research Site, Pembroke Pines, Florida
Research Site, Tampa, Florida
Research Site, Athens, Georgia
Research Site, Honolulu, Hawaii
Research Site, Baltimore, Maryland
Research Site, Minneapolis, Minnesota
Research Site, Saint Louis, Missouri
Research Site, Omaha, Nebraska
Research Site, Summit, New Jersey
Research Site, Mineola, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, New York, New York
Research Site, Charlotte, North Carolina
Research Site, Cleveland, Ohio
Research Site, North Charleston, South Carolina
Research Site, Nashville, Tennessee
Research Site, Nashville, Tennessee
Research Site, Richmond, Virginia
Research Site, Madison, Wisconsin
Research Site, Box Hill, Not set
Research Site, Gosford, Not set
Research Site, Kogarah, Not set
Research Site, Melbourne, Not set
Research Site, Port Macquarie, Not set
Research Site, Southport, Not set
Research Site, St Leonards, Not set
Research Site, Brussels, Not set
Research Site, Charleroi, Not set
Research Site, Duffel, Not set
Research Site, Leuven, Not set
Research Site, Liège, Not set
Research Site, Kingston, Ontario
Research Site, Newmarket, Ontario
Research Site, Oshawa, Ontario
Research Site, Sault Ste. Marie, Ontario
Research Site, St. Catharines, Ontario
Research Site, Sudbury, Ontario
Research Site, Toronto, Ontario
Research Site, Regina, Saskatchewan
Research Site, Saskatoon, Saskatchewan
Research Site, Bordeaux Cedex, Not set
Research Site, Brest Cedex, Not set
Research Site, Creteil, Not set
Research Site, Lille, Not set
Research Site, Lyon Cedex 08, Not set
Research Site, Marseille cedex, Not set
Research Site, Aachen, Not set
Research Site, Bad Berka, Not set
Research Site, Berlin, Not set
Research Site, Berlin, Not set
Research Site, Freiburg, Not set
Research Site, Gauting, Not set
Research Site, Hamburg, Not set
Research Site, Heidelberg, Not set
Research Site, Hemer, Not set
Research Site, Homburg/Saar, Not set
Research Site, Immenhausen, Not set
Research Site, Lubeck, Not set
Research Site, Löwenstein, Not set
Research Site, Mainz, Not set
Research Site, Münster, Not set
Research Site, Oldenburg, Not set
Research Site, Ulm, Not set
Research Site, Velbert, Not set
Research Site, Würzburg, Not set
Research Site, Budapest, Not set
Research Site, Deszk, Not set
Research Site, Edelény, Not set
Research Site, Kaposvár, Not set
Research Site, Kecskemét, Not set
Research Site, Miskolc, Not set
Research Site, Nyíregyháza, Not set
Research Site, Pécs, Not set
Research Site, Székesfehérvár, Not set
Research Site, Genova, Not set
Research Site, Meldola, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, Milano, Not set
Research Site, San Giovanni Rotondo, Not set
Research Site, Siena, Not set
Research Site, Fukushima-shi, Not set
Research Site, Himeji-shi, Not set
Research Site, Hirakata-shi, Not set
Research Site, Hirosaki-shi, Not set
Research Site, Iizuka-shi, Not set
Research Site, Iwakuni-shi, Not set
Research Site, Izumi-shi, Not set
Research Site, Kanazawa, Not set
Research Site, Kishiwada-shi, Not set
Research Site, Kobe-shi, Not set
Research Site, Koga-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Kyoto-shi, Not set
Research Site, Mitaka-shi, Not set
Research Site, Nagaoka-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Nagoya-shi, Not set
Research Site, Okayama-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osaka-shi, Not set
Research Site, Osakasayama, Not set
Research Site, Saga-shi, Not set
Research Site, Saitama-shi, Not set
Research Site, Sakai-shi, Not set
Research Site, Sendai-shi, Not set
Research Site, Shinjuku-ku, Not set
Research Site, Tokushima-shi, Not set
Research Site, Ube-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokohama-shi, Not set
Research Site, Yokosuka-shi, Not set
Research Site, Busan, Not set
Research Site, Changwon-si, Not set
Research Site, Cheongju-si, Not set
Research Site, Daegu, Not set
Research Site, Daegu, Not set
Research Site, Daejeon, Not set
Research Site, Goyang-si, Not set
Research Site, Incheon, Not set
Research Site, Jinju-si, Not set
Research Site, Seongnam-si, Not set
Research Site, Seongnam-Si, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Seoul, Not set
Research Site, Suwon-si, Not set
Research Site, Ulsan, Not set
Research Site, Amsterdam, Not set
Research Site, Arnhem, Not set
Research Site, Breda, Not set
Research Site, Den Bosch, Not set
Research Site, Groningen, Not set
Research Site, Maastricht, Not set
Research Site, Rotterdam, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Moscow, Not set
Research Site, Obninsk, Not set
Research Site, Omsk, Not set
Research Site, Saint Petersburg, Not set
Research Site, Saint-Petersburg, Not set
Research Site, St. Petersburg, Not set
Research Site, St. Petersburg, Not set
Research Site, A Coruña, Not set
Research Site, Alicante, Not set
Research Site, Barcelona, Not set
Research Site, Barcelona, Not set
Research Site, Gerona, Not set
Research Site, Jaén, Not set
Research Site, León, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Madrid, Not set
Research Site, Majadahonda, Not set
Research Site, Málaga, Not set
Research Site, Sevilla, Not set
Research Site, Sevilla, Not set
Research Site, Valencia, Not set
Research Site, Bellinzona, Not set
Research Site, Lausanne, Not set
Research Site, Kaohsiung, Not set
Research Site, Kaohsiung, Not set
Research Site, Taichung, Not set
Research Site, Tainan City, Not set
Research Site, Taipei, Not set
Research Site, Taipei, Not set
Research Site, Tao-Yuan, Not set
Research Site, Bangkok, Not set
Research Site, Chiang Mai, Not set
Research Site, Hat Yai, Not set
Research Site, Khon Kaen, Not set
Research Site, Hanoi City, Not set
Research Site, Hanoi, Not set
Research Site, Hanoi, Not set
Research Site, Ho Chi Minh city, Not set
Research Site, Ho Chi Minh, Not set
Research Site, Ho Chi Minh, Not set
Conditions: Non-Small-Cell Lung Carcinoma NSCLC
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
Active Not Recruiting
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to disease-free survival (DFS) as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to overall survival (OS). The primary hypotheses are that pembrolizumab + adjuvant chemotherapy is superior to placebo + adjuvant chemotherapy, with or without radiotherapy, wi... Read More
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to disease-free survival (DFS) as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to overall survival (OS). The primary hypotheses are that pembrolizumab + adjuvant chemotherapy is superior to placebo + adjuvant chemotherapy, with or without radiotherapy, with respect to DFS as assessed radiographically by the investigator or by histopathologic confirmation of suspected disease recurrence, and with respect to OS. Read Less
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
06/05/2025
Locations: University of Alabama - Birmingham ( Site 3061), Birmingham, Alabama +230 locations
University of Alabama - Birmingham ( Site 3061), Birmingham, Alabama
University of South Alabama, Mitchell Cancer Institute ( Site 3058), Mobile, Alabama
HonorHealth Research Institute - Biltmore ( Site 3043), Phoenix, Arizona
Arizona Oncology Associates PC- HOPE ( Site 3049), Tucson, Arizona
UCSD Moores Cancer Center ( Site 3053), La Jolla, California
University Of Colorado ( Site 3051), Aurora, Colorado
Smilow Cancer Hospital at Yale New Haven ( Site 3070), New Haven, Connecticut
Mount Sinai Cancer Center ( Site 3081), Miami Beach, Florida
Northside Hospital ( Site 3036), Atlanta, Georgia
Northwestern Memorial Hospital ( Site 3044), Chicago, Illinois
Parkview Cancer Institute ( Site 3067), Fort Wayne, Indiana
Indiana University Melvin and Bren Simon Cancer Center ( Site 3071), Indianapolis, Indiana
University of Iowa Hospital and Clinics ( Site 3046), Iowa City, Iowa
Norton Cancer Institute - St. Matthews ( Site 3056), Louisville, Kentucky
WK Physicians Network/Gynecologic Oncology Associates ( Site 3047), Shreveport, Louisiana
University of Massachusetts Medical School ( Site 3037), Worcester, Massachusetts
Montefiore Medical Center ( Site 3065), Bronx, New York
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 3076), Mineola, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 3042), New York, New York
Duke Cancer Center ( Site 3072), Durham, North Carolina
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 3080), Fargo, North Dakota
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C, Columbus, Ohio
Legacy Good Samaritan Medical Center ( Site 3033), Portland, Oregon
Sidney Kimmel Cancer Center - Jefferson Health ( Site 3078), Philadelphia, Pennsylvania
AHN West Penn Hospital ( Site 3060), Pittsburgh, Pennsylvania
Abington Hospital - Asplundh Cancer Center ( Site 3073), Willow Grove, Pennsylvania
Sanford Gynecology Oncology ( Site 3045), Sioux Falls, South Dakota
UT Southwestern Medical Center ( Site 3063), Dallas, Texas
VCU Massey Cancer Center ( Site 3068), Richmond, Virginia
Centro de Oncología e Investigación de Buenos Aires ( Site 1005), Berazategui, Buenos Aires
IDIM Instituto de Diagnostico e Investigaciones Metabolicas ( Site 1006), Caba, Buenos Aires
Instituto de Investigaciones Clinicas Mar del Plata ( Site 1003), Mar del Plata, Buenos Aires
Hospital Britanico de Buenos Aires ( Site 1002), Buenos Aires, Caba
Instituto de Oncologia de Rosario ( Site 1004), Rosario, Santa Fe
IDIM - Instituto de Diagnóstico e Investigaciones Metabólicas ( Site 1010), Buenos Aires, Not set
Hospital Aleman ( Site 1001), Buenos Aires, Not set
CEMIC ( Site 1009), Buenos Aires, Not set
Centro Oncologico Riojano Integral ( Site 1007), La Rioja, Not set
Medizinische Universitat Graz ( Site 2004), Graz, Steiermark
Medizinische Universitaet Innsbruck ( Site 2001), Innsbruck, Tirol
Saint-Luc UCL ( Site 2042), Bruxelles, Bruxelles-Capitale, Region De
C.I.U. Hopital Ambroise Pare ( Site 2039), Mons, Hainaut
CHR Verviers ( Site 2035), Verviers, Liege
OLV Ziekenhuis ( Site 2038), Aalst, Oost-Vlaanderen
AZ Maria Middelares Gent ( Site 2032), Gent, Oost-Vlaanderen
Universitair Ziekenhuis Gent ( Site 2037), Gent, Oost-Vlaanderen
AZ Nikolaas ( Site 2031), Sint-Niklaas, Oost-Vlaanderen
UZ Leuven ( Site 2040), Leuven, Vlaams-Brabant
AZ Groeninge ( Site 2036), Kortrijk, West-Vlaanderen
CHC - Groupe Sante ( Site 2041), Liege, Not set
CHU Liege Sart-Tilman ( Site 2044), Liege, Not set
Tom Baker Cancer Centre ( Site 3007), Calgary, Alberta
Kingston Health Sciences Centre ( Site 3003), Kingston, Ontario
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 3006), Montreal, Quebec
McGill University Health Centre ( Site 3005), Montreal, Quebec
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 3, Quebec City, Quebec
Centro Investigación del Cáncer James Lind ( Site 1061), Temuco, Araucania
Fundacion Arturo Lopez Perez FALP ( Site 1062), Santiago, Region M. De Santiago
Centro de Cancer Nuestra Senora de la Esperanza ( Site 1063), Santiago, Region M. De Santiago
Bradfordhill-Clinical Area ( Site 1070), Santiago, Region M. De Santiago
Oncocentro ( Site 1065), Vina del Mar, Valparaiso
Anhui Provincial Hospital-Obstetrics and Gynecology ( Site 4034), Hefei, Anhui
Beijing Cancer Hospital ( Site 4048), Beijing, Beijing
Peking Union Medical College Hospital ( Site 4036), Beijing, Beijing
Chongqing Cancer Hospital ( Site 4040), Chongqing, Chongqing
The First Affiliated Hospital of Xiamen University ( Site 4060), Xiamen, Fujian
The First Affiliated Hospital ( Site 4043), Guangzhou, Guangdong
Guangxi Medical University Affiliated Tumor Hospital ( Site 4049), Nanning, Guangxi
Harbin Medical University Cancer Hospital ( Site 4033), Harbin, Heilongjiang
Hubei Cancer Hospital ( Site 4059), Wuhan, Hubei
Xiangya Hospital Central-South University ( Site 4035), Changsha, Hunan
Hunan Cancer Hospital ( Site 4050), Changsha, Hunan
Nanjing Drum Tower Hospital ( Site 4037), Nanjing, Jiangsu
Jiangxi Maternal and Child Health Hospital ( Site 4051), Nanchang, Jiangxi
The First Bethune Hospital of Jilin University ( Site 4057), Changchun, Jilin
The First Affiliated Hospital of Xi an Jiaotong University ( Site 4045), XI An, Shaanxi
Obstetrics and Gynecology Hosp. Fudan University ( Site 4041), Shanghai, Shanghai
Shanghai Renji Hospital Affiliated to Jiao Tong University ( Site 4053), Shanghai, Shanghai
Shanghai First Maternity and Infant Hospital-Gynecology department ( Site 4001), Shanghai, Shanghai
Sichuan Cancer Hospital ( Site 4039), Chengdu, Sichuan
Tianjin Medical University Cancer Institute & Hospital ( Site 4054), Tianjin, Tianjin
Yunnan Province Cancer Hospital-Gynecology Department ( Site 4055), Kunming, Yunnan
The First Affiliated Hospital, Zhejiang University-Gynecology ( Site 4002), Hangzhou, Zhejiang
Women s Hospital School of Medicine Zhejiang University ( Site 4032), Hangzhou, Zhejiang
The First Affiliated Hospital of Wenzhou Medical University ( Site 4056), Wenzhou, Zhejiang
Clínica Vida Fundación - Sede Poblado ( Site 1096), Medellin, Antioquia
Instituto Nacional de Cancerología E.S.E ( Site 1094), Bogota, Distrito Capital De Bogota
Instituto Cancerologico de Narino Ltda ( Site 1092), San Juan De Pasto, Narino
Fundacion Valle del Lili ( Site 1093), Cali, Valle Del Cauca
Fakultní nemocnice Brno Bohunice-Gynekologicko-porodnicka klinika ( Site 2394), Brno, Brno-mesto
Fakultni nemocnice Kralovske Vinohrady ( Site 2393), Praha, Praha 10
Vseobecna fakultni nemocnice v Praze ( Site 2391), Praha, Praha 2
Fakultni nemocnice Olomouc ( Site 2392), Olomouc, Not set
Rigshospitalet University Hospital ( Site 2515), Copehagen, Hovedstaden
Herlev Hospital ( Site 2514), Herlev, Hovedstaden
Aalborg Universitetshospital ( Site 2511), Aalborg, Nordjylland
Roskilde Sygehus ( Site 2513), Roskilde, Sjaelland
Odense Universitetshospital ( Site 2512), Odense, Syddanmark
Tampere University Hospital ( Site 2541), Tampere, Pirkanmaa
Kuopio University Hospital ( Site 2543), Kuopio, Pohjois-Savo
Turku University Hospital ( Site 2542), Turku, Varsinais-Suomi
Institut De Cancerologie De Lorraine ( Site 2072), Vandoeuvre les Nancy, Ain
Centre Antoine Lacassagne ( Site 2073), Nice, Alpes-Maritimes
Centre Francois Baclesse ( Site 2062), Caen, Calvados
Hôpital Privé Des Côtes d'Armor ( Site 2063), Plérin, Cotes-d Armor
CHU Besancon - Hopital Jean Minjoz ( Site 2068), Besancon, Doubs
Institut Bergonie ( Site 2067), Bordeaux, Gironde
Institut Universitaire du Cancer Toulouse - Oncopole ( Site 2065), Toulouse, Haute-Garonne
Institut Regional du Cancer de Montpellier - ICM ( Site 2069), Montpellier, Herault
Hopital Cochin ( Site 2070), Paris, Ile-de-France
Gustave Roussy ( Site 2071), Villejuif, Ile-de-France
Hopital prive du Confluent ( Site 2061), Nantes, Loire-Atlantique
Centre Hospitalier Lyon Sud ( Site 2064), Pierre Benite, Rhone
SLK-Kliniken Heilbronn GmbH ( Site 2116), Heilbronn, Baden-Wurttemberg
Klinikum Ludwigsburg ( Site 2111), Ludwigsburg, Baden-Wurttemberg
Universitaetsklinikum Tuebingen ( Site 2113), Tübingen, Baden-Wurttemberg
Medizinische Hochschule Hannover-Department of Obstetrics and Gynecology ( Site 2109), Hannover, Niedersachsen
Universitätsklinikum Bonn-Gynaecological oncology ( Site 2103), Bonn, Nordrhein-Westfalen
Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung ( Site 2105), Essen, Nordrhein-Westfalen
Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Frauenheilkunde und Gebur, Dresden, Sachsen
Universitätsklinikum Schleswig-Holstein ( Site 2101), Lübeck, Schleswig-Holstein
General Hospital of Patras. St Andrews ( Site 2421), Patras, Achaia
Geniko Panepistimako Nosokomeio ARETEIO ( Site 2423), Athens, Attiki
Perifereiako Geniko Nosokomeio ALEXANDRA ( Site 2425), Athens, Attiki
Athens University Hospital ATTIKON ( Site 2424), Chaidari, Attiki
Hospital Hygeia ( Site 2426), Marousi, Attiki
Euromedica General Clinic of Thessaloniki ( Site 2422), Thessaloniki, Not set
Rambam Medical Center ( Site 2307), Haifa, Not set
Edith Wolfson Medical Center ( Site 2306), Holon, Not set
Hadassah Medical Center. Ein Kerem ( Site 2303), Jerusalem, Not set
Rabin Medical Center ( Site 2305), Petah Tikva, Not set
Chaim Sheba Medical Center ( Site 2301), Ramat Gan, Not set
Istittuto Nazionale dei Tumori Regina Elena IRCCS - IFO ( Site 2121), Roma, Abruzzo
Fondazione Policlinico Universitario Agostino Gemelli ( Site 2124), Roma, Lazio
Istituto di Candiolo - IRCCS ( Site 2125), Candiolo, Piemonte
Azienda Ospedaliera Spedali Civili di Brescia ( Site 2135), Brescia, Not set
IRCCS Ospedale San Raffaele ( Site 2130), Milano, Not set
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 2122), Milano, Not set
Istituto Europeo di Oncologia IRCCS-Divisione di Ginecologia Oncologica ( Site 2132), Milano, Not set
Azienda Ospedaliera Universitaria Federico II ( Site 2123), Napoli, Not set
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 2127), Napoli, Not set
Istituto Oncologico Veneto IRCCS-Oncologia 2 ( Site 2134), Padova, Not set
Aichi Cancer Center Hospital ( Site 4190), Nagoya, Aichi
National Cancer Center Hospital East ( Site 4197), Kashiwa, Chiba
National Hospital Organization Shikoku Cancer Center ( Site 4181), Matsuyama, Ehime
Ehime University Hospital ( Site 4187), Toon, Ehime
Kurume University Hospital ( Site 4186), Kurume, Fukuoka
Gunma Prefectural Cancer Center ( Site 4183), Ota, Gunma
Hokkaido University Hospital ( Site 4194), Sapporo, Hokkaido
Hyogo Cancer Center ( Site 4195), Akashi, Hyogo
Iwate Medical University Hospital ( Site 4189), Shiwa-gun, Iwate
University of the Ryukyus Hospital ( Site 4184), Nakagami-gun, Okinawa
Saitama Medical University International Medical Center ( Site 4182), Hidaka, Saitama
Shizuoka Cancer Center Hospital and Research Institute ( Site 4192), Sunto-gun, Shizuoka
National Hospital Organization Kyushu Cancer Center ( Site 4193), Fukuoka, Not set
Niigata Cancer Center Hospital ( Site 4185), Niigata, Not set
Osaka International Cancer Institute ( Site 4188), Osaka, Not set
The Cancer Institute Hospital of JFCR ( Site 4196), Tokyo, Not set
Keio University Hospital ( Site 4191), Tokyo, Not set
National Cancer Center ( Site 4065), Goyang-si, Kyonggi-do
Seoul National University Bundang Hospital ( Site 4063), Seongnam-si, Kyonggi-do
Severance Hospital Yonsei University Health System ( Site 4062), Seoul, Not set
Asan Medical Center ( Site 4061), Seoul, Not set
Samsung Medical Center ( Site 4064), Seoul, Not set
Investigacion Onco Farmaceutica S de RL de CV ( Site 1127), La Paz, Baja California Sur
Hospital San Lucas Cardiologica del Sureste ( Site 1122), Tuxtla Gutierrez, Chiapas
Instituto Nacional de Cancerologia ( Site 1124), Cdmx, Distrito Federal
Christus Muguerza Clinica Vidriera ( Site 1125), Monterrey, Nuevo Leon
I Can Oncology Center SA de CV ( Site 1126), Monterrey, Nuevo Leon
Hospital Angeles Roma ( Site 1123), Ciudad de Mexico, Not set
Centro Oncologico Internacional. SEDNA ( Site 1121), Mexico City, Not set
University Hospital of North Norway ( Site 2153), Tromso, Troms
Soerlandet sykehus HF Kristiansand ( Site 2152), Kristiansand, Vest-Agder
Oslo Universitetssykehus Radiumhospitalet ( Site 2151), Oslo, Not set
Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 2487), Siedlce, Mazowieckie
Szpital Kliniczny im Ks Anny Mazowieckiej ( Site 2481), Warszawa, Mazowieckie
Bialostockie Centrum Onkologii ( Site 2483), Bialystok, Podlaskie
Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 2482), Gliwice, Slaskie
Swietokrzyskie Centrum Onkologii SPZOZ ( Site 2485), Kielce, Swietokrzyskie
SPZOZ MSWIA z Warminsko-Mazurskim Centrum Onkologii w Olsztynie ( Site 2486), Olsztyn, Warminsko-mazurskie
Wielkopolskie Centrum Onkologii im.M.Sklodowskiej-Curie ( Site 2484), Poznan, Wielkopolskie
Arkhangelsk Clinical Oncological Dispensary ( Site 2637), Arkhangelsk, Arkhangel Skaya Oblast
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 2645), Ufa, Baskortostan, Respublika
Chelyabinsk Regional Clinical Center Oncology and Nuclear Medicine ( Site 2644), Chelyabinsk, Chelyabinskaya Oblast
Krasnoyarsk Regional Clinical oncology dispensary ( Site 2643), Krasnoyarsk, Krasnoyarskiy Kray
National Research Ogarev Mordovia State University ( Site 2648), Saransk, Mordoviya, Respublika
FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 2634), Moscow, Moskva
Moscow Research Oncology Institute named after P.A. Hertsen ( Site 2631), Moscow, Moskva
Nizhegorodsky Regional Oncology Dispensary-chemotherapy department (Branch№1) ( Site 2639), Nizhniy Novgorod, Nizhegorodskaya Oblast
Samara Regional Clinical Oncology Center-Chemotherapy Dapartment ( Site 2649), Samara, Samarskaya Oblast
Scientific Research Oncology Institute n.a. N.N.Petrov ( Site 2636), Saint-Petersburg, Sankt-Peterburg
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2646), Kazan, Tatarstan, Respublika
Tomsk Scientific Research Institute of Oncology-Chemotherapy ( Site 2638), Tomsk, Tomskaya Oblast
Yaroslavl Regional SBIH Clinical Oncology Hospital ( Site 2641), Yaroslavl, Yaroslavskaya Oblast
Hospital Josep Trueta ( Site 2184), Girona, Gerona
Clinica Universitaria de Navarra ( Site 2181), Madrid, Madrid, Comunidad De
Hospital Vall D Hebron ( Site 2182), Barcelona, Not set
Hospital Clinic i Provincial ( Site 2185), Barcelona, Not set
Hospital Universitario Reina Sofia ( Site 2183), Cordoba, Not set
Hospital Clinico San Carlos ( Site 2187), Madrid, Not set
Hospital Universitario La Paz ( Site 2186), Madrid, Not set
Universitetssjukhuset i Linkoping. ( Site 2222), Linkoping, Ostergotlands Lan
Karolinska Universitetssjukhuset Solna ( Site 2220), Solna, Stockholms Lan
Blod-och Tumorsjukdomar ( Site 2221), Uppsala, Uppsala Lan
Changhua Christian Hospital ( Site 4095), Changhua, Not set
Taichung Veterans General Hospital ( Site 4094), Taichung, Not set
MacKay Memorial Hospital ( Site 4092), Taipei, Not set
Taipei Veterans General Hospital ( Site 4093), Taipei, Not set
Linkou Chang Gung Memorial Hospital ( Site 4091), Taoyuan, Not set
Baskent Adana Dr Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 2355), Adana, Not set
Cukurova Uni. Tip Fakultesi ( Site 2353), Adana, Not set
Baskent Universitesi Ankara Hastanesi ( Site 2354), Ankara, Not set
Ankara Universitesi Tıp Fakultesi Hastanesi ( Site 2350), Ankara, Not set
Medipol Universite Hastanesi ( Site 2352), Istanbul, Not set
Ege University Medical Faculty ( Site 2351), Izmir, Not set
I.E.U. Medical Point Hastanesi ( Site 2356), Izmir, Not set
Chernihiv Medical Center of Modern Oncology ( Site 2368), Chernihiv, Chernihivska Oblast
Municipal Enterprise "Bukovinian сlinical oncology сenter" ( Site 2366), Chernivtsi, Chernivetska Oblast
SO Grigoriev Institute for Medical Radiology and Oncology of NAMS of Ukraine ( Site 2363), Kharkiv, Kharkivska Oblast
MNE "Khmelnytskyi regional antitumor center" ( Site 2365), Khmelnitskyi, Khmelnytska Oblast
LISOD - Israeli Oncological Hospital MedX-ray International Group, LLC ( Site 2364), Kiev, Kyivska Oblast
Lviv State Regional Oncological Center ( Site 2361), Lviv, Lvivska Oblast
The Municipal Enterprise Volyn Regional Medical Oncology Centre ( Site 2362), Lutsk, Volynska Oblast
Bristol Haematology and Oncology Centre ( Site 2244), Bristol, Bristol, City Of
Castle Hill Hospital-Academic Oncology ( Site 2252), Cottingham, East Riding Of Yorkshire
Beatson West of Scotland Cancer Centre ( Site 2247), Glasgow, Glasgow City
UCLH NHS Foundation Trust ( Site 2242), London, London, City Of
Royal Marsden NHS Foundation Trust ( Site 2248), London, London, City Of
Royal Marsden Hospital Sutton-Surrey ( Site 2241), Sutton, London, City Of
Leicester Royal Infirmary. Univ. Hosp. of Leicester NHS Trust ( Site 2249), Leicester, Not set
The Christie Hospital NHS Foundation Trust ( Site 2243), Manchester, Not set
Conditions: Endometrial Neoplasms
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
Active Not Recruiting
This phase III trial studies different chemotherapy and radiation therapy regimens to compare how well they work in treating young patients with newly diagnosed, previously untreated, high-risk medulloblastoma. Chemotherapy drugs, such as vincristine sulfate, cisplatin, cyclophosphamide, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination... Read More
This phase III trial studies different chemotherapy and radiation therapy regimens to compare how well they work in treating young patients with newly diagnosed, previously untreated, high-risk medulloblastoma. Chemotherapy drugs, such as vincristine sulfate, cisplatin, cyclophosphamide, and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Radiation therapy uses high-energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. Carboplatin may make tumor cells more sensitive to radiation therapy. It is not yet known which chemotherapy and radiation therapy regimen is more effective in treating brain tumors. Read Less
Gender:
ALL
Ages:
Between 3 years and 22 years
Trial Updated:
06/04/2025
Locations: Children's Hospital of Alabama, Birmingham, Alabama +184 locations
Children's Hospital of Alabama, Birmingham, Alabama
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Providence Alaska Medical Center, Anchorage, Alaska
Banner Children's at Desert, Mesa, Arizona
Arkansas Children's Hospital, Little Rock, Arkansas
Loma Linda University Medical Center, Loma Linda, California
Miller Children's and Women's Hospital Long Beach, Long Beach, California
Children's Hospital Los Angeles, Los Angeles, California
Cedars Sinai Medical Center, Los Angeles, California
Valley Children's Hospital, Madera, California
UCSF Benioff Children's Hospital Oakland, Oakland, California
Kaiser Permanente-Oakland, Oakland, California
Children's Hospital of Orange County, Orange, California
Lucile Packard Children's Hospital Stanford University, Palo Alto, California
Sutter Medical Center Sacramento, Sacramento, California
University of California Davis Comprehensive Cancer Center, Sacramento, California
Rady Children's Hospital - San Diego, San Diego, California
UCSF Medical Center-Parnassus, San Francisco, California
UCSF Medical Center-Mission Bay, San Francisco, California
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California
Children's Hospital Colorado, Aurora, Colorado
Connecticut Children's Medical Center, Hartford, Connecticut
Yale University, New Haven, Connecticut
Alfred I duPont Hospital for Children, Wilmington, Delaware
MedStar Georgetown University Hospital, Washington, District of Columbia
Children's National Medical Center, Washington, District of Columbia
Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida
Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida
Nemours Children's Clinic-Jacksonville, Jacksonville, Florida
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Nicklaus Children's Hospital, Miami, Florida
AdventHealth Orlando, Orlando, Florida
Arnold Palmer Hospital for Children, Orlando, Florida
Nemours Children's Hospital, Orlando, Florida
Nemours Children's Clinic - Pensacola, Pensacola, Florida
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida
Tampa General Hospital, Tampa, Florida
Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida
Saint Mary's Medical Center, West Palm Beach, Florida
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia
Memorial Health University Medical Center, Savannah, Georgia
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii
Saint Luke's Cancer Institute - Boise, Boise, Idaho
Lurie Children's Hospital-Chicago, Chicago, Illinois
University of Illinois, Chicago, Illinois
University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Loyola University Medical Center, Maywood, Illinois
Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois
Advocate Children's Hospital-Park Ridge, Park Ridge, Illinois
Advocate Lutheran General Hospital, Park Ridge, Illinois
Saint Jude Midwest Affiliate, Peoria, Illinois
Southern Illinois University School of Medicine, Springfield, Illinois
Riley Hospital for Children, Indianapolis, Indiana
Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana
Blank Children's Hospital, Des Moines, Iowa
University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa
University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Norton Children's Hospital, Louisville, Kentucky
Children's Hospital New Orleans, New Orleans, Louisiana
Eastern Maine Medical Center, Bangor, Maine
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Walter Reed National Military Medical Center, Bethesda, Maryland
Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Dana-Farber Cancer Institute, Boston, Massachusetts
Baystate Medical Center, Springfield, Massachusetts
C S Mott Children's Hospital, Ann Arbor, Michigan
Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Henry Ford Health Saint John Hospital, Detroit, Michigan
Michigan State University Clinical Center, East Lansing, Michigan
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan
Bronson Methodist Hospital, Kalamazoo, Michigan
Kalamazoo Center for Medical Studies, Kalamazoo, Michigan
Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota
University of Mississippi Medical Center, Jackson, Mississippi
University of Missouri Children's Hospital, Columbia, Missouri
Children's Mercy Hospitals and Clinics, Kansas City, Missouri
Cardinal Glennon Children's Medical Center, Saint Louis, Missouri
Washington University School of Medicine, Saint Louis, Missouri
Mercy Hospital Saint Louis, Saint Louis, Missouri
Children's Hospital and Medical Center of Omaha, Omaha, Nebraska
University Medical Center of Southern Nevada, Las Vegas, Nevada
Sunrise Hospital and Medical Center, Las Vegas, Nevada
Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada
Summerlin Hospital Medical Center, Las Vegas, Nevada
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon, New Hampshire
Hackensack University Medical Center, Hackensack, New Jersey
Saint Barnabas Medical Center, Livingston, New Jersey
Morristown Medical Center, Morristown, New Jersey
Saint Peter's University Hospital, New Brunswick, New Jersey
Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey
Newark Beth Israel Medical Center, Newark, New Jersey
Saint Joseph's Regional Medical Center, Paterson, New Jersey
Overlook Hospital, Summit, New Jersey
University of New Mexico Cancer Center, Albuquerque, New Mexico
Albany Medical Center, Albany, New York
Montefiore Medical Center - Moses Campus, Bronx, New York
Roswell Park Cancer Institute, Buffalo, New York
NYU Langone Hospital - Long Island, Mineola, New York
The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Mount Sinai Hospital, New York, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
Memorial Sloan Kettering Cancer Center, New York, New York
University of Rochester, Rochester, New York
Stony Brook University Medical Center, Stony Brook, New York
State University of New York Upstate Medical University, Syracuse, New York
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina
Novant Health Presbyterian Medical Center, Charlotte, North Carolina
Wake Forest University Health Sciences, Winston-Salem, North Carolina
Sanford Broadway Medical Center, Fargo, North Dakota
Children's Hospital Medical Center of Akron, Akron, Ohio
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Rainbow Babies and Childrens Hospital, Cleveland, Ohio
Cleveland Clinic Foundation, Cleveland, Ohio
Nationwide Children's Hospital, Columbus, Ohio
Dayton Children's Hospital, Dayton, Ohio
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio
Mercy Children's Hospital, Toledo, Ohio
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
Legacy Emanuel Children's Hospital, Portland, Oregon
Legacy Emanuel Hospital and Health Center, Portland, Oregon
Oregon Health and Science University, Portland, Oregon
Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania
Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania
Geisinger Medical Center, Danville, Pennsylvania
Penn State Children's Hospital, Hershey, Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania
Medical University of South Carolina, Charleston, South Carolina
Prisma Health Richland Hospital, Columbia, South Carolina
BI-LO Charities Children's Cancer Center, Greenville, South Carolina
Greenville Cancer Treatment Center, Greenville, South Carolina
Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota
T C Thompson Children's Hospital, Chattanooga, Tennessee
East Tennessee Childrens Hospital, Knoxville, Tennessee
The Children's Hospital at TriStar Centennial, Nashville, Tennessee
Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Texas Tech University Health Sciences Center-Amarillo, Amarillo, Texas
Dell Children's Medical Center of Central Texas, Austin, Texas
Driscoll Children's Hospital, Corpus Christi, Texas
Medical City Dallas Hospital, Dallas, Texas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Cook Children's Medical Center, Fort Worth, Texas
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas
M D Anderson Cancer Center, Houston, Texas
Covenant Children's Hospital, Lubbock, Texas
UMC Cancer Center / UMC Health System, Lubbock, Texas
Children's Hospital of San Antonio, San Antonio, Texas
Methodist Children's Hospital of South Texas, San Antonio, Texas
University of Texas Health Science Center at San Antonio, San Antonio, Texas
Scott and White Memorial Hospital, Temple, Texas
Primary Children's Hospital, Salt Lake City, Utah
University of Vermont and State Agricultural College, Burlington, Vermont
Inova Fairfax Hospital, Falls Church, Virginia
Children's Hospital of The King's Daughters, Norfolk, Virginia
Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia
Carilion Children's, Roanoke, Virginia
Seattle Children's Hospital, Seattle, Washington
Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington
Mary Bridge Children's Hospital and Health Center, Tacoma, Washington
Madigan Army Medical Center, Tacoma, Washington
West Virginia University Charleston Division, Charleston, West Virginia
West Virginia University Healthcare, Morgantown, West Virginia
Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin
Marshfield Medical Center-Marshfield, Marshfield, Wisconsin
Children's Hospital of Wisconsin, Milwaukee, Wisconsin
Women's and Children's Hospital-Adelaide, North Adelaide, South Australia
Princess Margaret Hospital for Children, Perth, Western Australia
University of Alberta Hospital, Edmonton, Alberta
British Columbia Children's Hospital, Vancouver, British Columbia
CancerCare Manitoba, Winnipeg, Manitoba
IWK Health Centre, Halifax, Nova Scotia
McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario
Children's Hospital of Eastern Ontario, Ottawa, Ontario
Hospital for Sick Children, Toronto, Ontario
The Montreal Children's Hospital of the MUHC, Montreal, Quebec
Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec
Saskatoon Cancer Centre, Saskatoon, Saskatchewan
CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Quebec, Not set
Dutch Childhood Oncology Group, Utrecht, Not set
University Pediatric Hospital, San Juan, Not set
Conditions: Anaplastic Medulloblastoma, Medulloblastoma
61 - 72 of 326